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DESIGN OF A DRUG DELIVERY
SYSTEM THROUGH THE
GASTROINTESTINAL TRACT

INTRODUCTION
Alzheimer’s disease (AD) drugs are commonly administered
orally, requiring passage through the gastrointestinal (GI)
tract before entering the bloodstream. While in the GI tract,
much of the drug is broken down by catalytic enzymes before
being reabsorbed by the small intestines or denatured due to
the varying levels of pH. Orally ingested drugs are
predominantly excreted from the body, making the design of
a high efficacy delivery system a priority.

Once entering the duodenum of the small intestine, the rise
in pH will cause the hydrogel to swell and release the drug.
This will lead to subsequent digestion and absorption in the
small intestine.
FITC, a fluorescent dye, was used to mimic Memantine in
the PEGDA hydrogels and were placed in separate vials
containing different pH levels found in the GI Tract.
NanoDrop Spectrophotometry was used to determine the
amount of fluorescence in each vial after varying time points.

Figure 2: PEGDA hydrogel prior to
UV
catalysis
(Left).
PEGDA
hydrogel during UV catalysis
(Middle). PEGDA hydrogel after 30
minutes of UV catalysis (Right)

OBJECTIVE
Enhance the delivery of Memantine through the GI tract to
increase drug bioavailability

DESIGN

RESULTS

A PEGDA (polyethylene glycol
diacrylate) hydrogel coating
containing
PMMAcoMA
[poly(methyl methacrylate-comethacrylic acid)] will be used
for the delivery of Memantine.
This drug delivery system will
be used to enhance pH
reactivity
and
prolong
digestion. pH sensitivity will
prevent the drug from releasing
within the stomach where
minimal absorption occurs.

Fluorescent release was found to be maximum at a pH of 7.4
followed by a pH of 6, 5, 4, and 3 respectively.

Figure 4: The dehydrated hydrogel displayed RFU values well below the respective values
for the hydrated hydrogel. The overall relationship; however, remains the same in both
sets of data.

CONCLUSION
In all of the trials testing the PEGDA/PMMA-co-MA hydrogel,
the drug delivery system demonstrated the desired decrease
in swelling with decrease in solution pH, assessed using
fluorescent FITC as the model for the drug. The design allows
for the desired drug, memantine, to be carried through the
acidic environment of the stomach to be released ultimately
in the small intestine where the pH increases. This expected
change in swelling due to changes in pH is due to PMMA-coMA’s anionic nature that carries a charge in less acidic
environments to allow swelling and release of its contents.
Although the desired correlation was observed between
swelling and pH, the design can be improved by adjusting the
polymer ratios to minimize swelling at more acidic pHs.
Further experimentation could also include replacing the
FITC in the design with the actual drug of choice.
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Figure 1: pH levels in the GI Tract

Figure 3: Average relative fluorescence over time at various pH levels

